Revolution Medicines, Inc. (RVMD) has a market capitalization of $29.13B and trades at $147.01. The 52-week range is 29.17-124.49.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -24.7, Earnings Per Share (EPS) of $-5.95.
The stock has a beta of 1.01, operates in the Healthcare sector.
